Delivery Order SPE2DB22D9304-SPE2DB24FSSL0
Award Date 1/10/24
Potential Completion Date 2/1/24
Potential Value $57K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563711556 - MACI 3CM X 5CM IMPLANT SHEETS. The delivery order, with a potential value of $57,317.20 and a completion date of January 31, 2024, is issued against an existing indefinite delivery contract that DMS Pharmaceutical Group holds with DLA to supply a variety of pharmaceuticals and medical supplies to military treatment facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a $57,317.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of MACI 3CM X 5CM IMPLANT SHEETS. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $53,318.24, is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS to support the recurring medical supply needs of military health facilities. This Delivery Order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563200326 MACI 3CM X 5CM IMPLANT SHEETS. The contract has a total potential value of $53,318.24 and a completion date of December 19, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA Troop Support Medical to supply a variety of pharmaceuticals and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency has awarded a $57,317.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4563711559 MACI 3CM X 5CM implant sheets. This delivery order was issued under an existing indefinite delivery contract held by DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support the operations of military treatment facilities worldwide. DMS Pharmaceutical Group has extensive experience...
- This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, with a ceiling value of $57,317.20 and a performance period ending on August 28, 2024. The contract type is Firm Fixed Price. DMS Pharmaceutical Group Inc. is the prime contractor, and there is no set-aside designation for this award. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $57,317.20 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for the delivery of 4563979258 - MACI 3CM X 5CM IMPLANT SHEETS. This order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, with a potential value of up to $4,999,999 through 2025. Through this IDV, DLA can issue delivery orders for a broad...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of MACI 3CM X 5CM IMPLANT SHEETS. The $57,317.20 firm fixed-price contract has a completion date of May 1, 2024 and was awarded on April 10, 2024. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB22D9112 with the DLA, valued up to $4,999,999 through 2025, which allows the agency...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4560447168 - MACI 3CM X 5CM IMPLANT SHEET 2S. The $106,636.46 contract has a completion date of April 3, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a full suite of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense. The company...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB24FSSL0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563711558 - MACI 3CM X 5CM IMPLANT SHEETS. The potential value of this delivery order is $57,317.20. The delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. This contract does not have a set-aside designation.
Generated 4/10/24, 10:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.3k | 1/10/24 |